Logo Image
|Articles|November 1, 1996

Oncology NEWS International

  • Oncology NEWS International Vol 5 No 11
  • Volume 5
  • Issue 11

FDA Approves Xillix LIFE-Lung System

ROCKVILLE, Md-The FDA has given final approval to the Xillix LIFE-Lung Fluorescence Endoscopy System for use in detecting early lung cancer. Xillix Technologies Corp., of Richmond, British Columbia, plans to market the system worldwide in early 1997.

ROCKVILLE, Md—The FDA has given final approval to the Xillix LIFE-Lung Fluorescence Endoscopy System for use in detecting early lung cancer. Xillix Technologies Corp., of Richmond, British Columbia, plans to market the system worldwide in early 1997.

Articles in this issue

almost 30 years ago

Factor Analysis of New Symptom Scale in Breast Cancer Finds Six Clusters

almost 30 years ago

AIDS Funding Increased for Fiscal '97

almost 30 years ago

'Cancer Rates and Risks' Available

almost 30 years ago

New Breast Cancer Patient Resource Is Available

almost 30 years ago

Short-Term Metronidazole not Linked to Cancer

almost 30 years ago

Various Capitation Models Are Available for Oncology Networks

almost 30 years ago

NCI Urges full Disclosure of Cigarette Contents

almost 30 years ago

Antifungal Resistance on the Increase

almost 30 years ago

Fentanyl Patch Useful Alternative in Cancer Pain Patients

almost 30 years ago

Analysis of Microvessel Density Predicts Extraprostatic Spread

Related to this article

View more